GSK Canada and Pan-Canadian Pharmaceutical Alliance sign LOI for Blenrep
GSK Canada and the Pan-Canadian Pharmaceutical Alliance signed a letter of intent (LOI) related to Blenrep for a type of multiple myeloma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.